Stent Retrievers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
All the vital news, analysis, and commentary curated by our industry experts.
Stent Retrievers Pipeline Market Report Overview
Stent retrievers are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached. One unit refers to one stent retriever.
The stent retrievers pipeline market research report provides comprehensive information about the Stent retrievers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
|Key Territories||· The US
|Key Regulatory Paths||· 510(k)
|Leading Companies||· Amnis Therapeutics Ltd
· Biomedical Solutions Inc
· Capital Medical University
· HeMo Bioengineering Ltd
· Insera Therapeutics LLC
|Enquire & Decide||Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.|
Stent Retrievers Pipeline Market Segmentation by Territories
Some of the key territories in the stent retrievers market are the US, Europe, China, Australia, and India among others. As of July 2023, the US had the highest number of pipeline products.
Stent Retrievers Pipeline Market Analysis by Territories, 2023 (%)
For more territory insights into the Stent retrievers pipeline market, download a free report sample
Stent Retrievers Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths in the Stent retrievers pipeline market are 510(k), ICAC, CE, NMPA, and TGA among others. As of July 2023, 510(k) was the most followed pathway for pipeline products.
Stent Retrievers Pipeline Market Analysis by Regulatory Paths, 2023 (%)
For more regulatory path insights into the Stent retrievers pipeline market, download a free report sample
Stent Retrievers Pipeline Market – Competitive Landscape
Some of the key companies in the stent retrievers pipeline market are Amnis Therapeutics Ltd, Biomedical Solutions Inc, Capital Medical University, HeMo Bioengineering Ltd, and Insera Therapeutics LLC among others.
Amnis Therapeutics Ltd: Amnis Therapeutics Ltd (Amnis Therapeutics), formerly ITGI Medical Ltd, is a biomedical engineering company that offers research, development, design, manufacture, and commercialization of medical devices for endovascular indications. The company offers Aneugraft Dx and Aneugraft Nx, biologically covered coronary stents, which facilitate immediate blood vessel reconstruction. Amnis Therapeutics is headquartered in Or Akiva, Israel.
Leading Stent Retrievers Companies, 2023
For more company insights into the Stent retrievers pipeline market, download a free report sample
Segments Covered in the Report
Stent Retrievers Pipeline Market Territories Outlook
- The US
Stent Retrievers Pipeline Market Regulatory Paths Outlook
This report provides:
- Extensive coverage of the stent retrievers is under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- Reviews of the major players involved in the development of stent retrievers and lists of all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
- Key clinical trial data of ongoing trials specific to pipeline products.
- Recent developments in the industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of Stent retrievers under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Biomedical Solutions Inc
Capital Medical University
HeMo Bioengineering Ltd
Insera Therapeutics LLC
MicroPort NeuroTech Ltd
MiVi Neuroscience LLC
Nanjing Kanite Medical Technology Co Ltd
NeuroVasc Technologies Inc
Perflow Medical, Ltd.
Shanghai HeartCare Medical Technology Co Ltd
Shanghai MicroPort Medical Group Co Ltd
SinoMedCare Biotech Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Triticum Medical Ltd.
Zhejiang Kindly Medical Devices Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd
Table of Contents
- 1 Table of Contents
- 2 Introduction
- 2.1 Stent Retrievers Overview
- 3 Products under Development
- 3.1 Stent Retrievers – Pipeline Products by Stage of Development
- 3.2 Stent Retrievers – Pipeline Products by Territory
- 3.3 Stent Retrievers – Pipeline Products by Regulatory Path
- 3.4 Stent Retrievers – Pipeline Products by Estimated Approval Date
- 3.5 Stent Retrievers – Ongoing Clinical Trials
- 4 Stent Retrievers – Pipeline Products under Development by Companies
- 4.1 Stent Retrievers Companies – Pipeline Products by Stage of Development
- 4.2 Stent Retrievers – Pipeline Products by Stage of Development
- 5 Stent Retrievers Companies and Product Overview
- 5.1 Amnis Therapeutics Ltd Company Overview
- 5.1.1 Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Biomedical Solutions Inc Company Overview
- 5.2.1 Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 Capital Medical University Company Overview
- 5.3.1 Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 HeMo Bioengineering Ltd Company Overview
- 5.4.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 Insera Therapeutics LLC Company Overview
- 5.5.1 Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 Medtronic Plc Company Overview
- 5.6.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 MicroPort NeuroTech Ltd Company Overview
- 5.7.1 MicroPort NeuroTech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 MiVi Neuroscience LLC Company Overview
- 5.8.1 MiVi Neuroscience LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Nanjing Kanite Medical Technology Co Ltd Company Overview
- 5.9.1 Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 NeuroVasc Technologies Inc Company Overview
- 5.10.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 OrbusNeich Company Overview
- 5.11.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Perflow Medical, Ltd. Company Overview
- 5.12.1 Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 Rapid Medical Company Overview
- 5.13.1 Rapid Medical Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 Shanghai HeartCare Medical Technology Co Ltd Company Overview
- 5.14.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Shanghai MicroPort Medical Group Co Ltd Company Overview
- 5.15.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 SinoMedCare Biotech Co Ltd Company Overview
- 5.16.1 SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
- 5.17.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Triticum Medical Ltd. Company Overview
- 5.18.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 Vesalio LLC Company Overview
- 5.19.1 Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 Zhejiang Kindly Medical Devices Co Ltd Company Overview
- 5.20.1 Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
- 5.21.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.1 Amnis Therapeutics Ltd Company Overview
- 6 Stent Retrievers- Recent Developments
- 6.1 Jun 06, 2023: Zylox-tonbridge Medical Technology Co. Announces Poll Results of the 2022 Annual General Meeting
- 6.2 Mar 30, 2023: Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by
87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million
- 6.3 Sep 15, 2022: Zylox-Tonbridge Medical Technology Co Ltd announced interim report for 2022
- 7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
Frequently asked questions
Which territory has the highest number of pipeline products in the stent retrievers pipeline market?
As of July 2023, the US had the highest number of pipeline products in the stent retrievers pipeline market.
Which was the most followed regulatory pathway in the stent retrievers pipeline market?
As of July 2023, 510(k) was the most followed regulatory pathway in the stent retrievers pipeline market.
Who are the major players operating in the stent retrievers pipeline market?
Some of the key companies in the Stent retrievers pipeline market are Amnis Therapeutics Ltd, Biomedical Solutions Inc, Capital Medical University, HeMo Bioengineering Ltd, and Insera Therapeutics LLC among others.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.